NSABP Members' Area
  Password Protected - Access
  Limited to NSABP Participating
  Institutions Only


NSABP Foundation, Inc.



General NSABP Information
  Financial Conflicts of
     Interest Policy
  Coalition Comment:
     Reconfiguration
  IOM Report Group Comment
  Contact the NSABP
  Pathology Section
  Future Meetings
  NSABP Newsletters
  Media Info on STAR
  Employment

Clinical Trials Information
  Clinical Trials Overview
  Protocol Chart
  Never Say Lost

Treatment Trials Information
  Protocol B-43
  Protocol B-47
  Protocol B-51

Prevention Trials Information
  Protocol P-1 - BCPT
  Protocol P-2 - STAR
  Protocol P-5
  BreastCancerPrevention.com

Scientific Publications

Related Web Sites



Medical Search Engines



To report problems, ask
questions or make comments,
please send e-mail to:
Webmaster@nsabp.pitt.edu

NSABP Clinical Trials Overview


Protocol B-28
A Randomized Trial Comparing the Worth of Paclitaxel (Taxol) Following Doxorubicin (Adriamycin) /Cyclophosphamide in Breast Cancer Patients With Positive Axillary Nodes

Specific Aims
The primary aim of this study is to determine whether four cycles of Taxol given after four cycles of postoperative AC will more effectively prolong disease-free survival and survival than do four cycles of AC alone, in patients with operable breast cancer who have one or more histologically positive axillary lymph nodes.